Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
The closing price of Geron Corp (NASDAQ: GERN) was $1.33 for the day, up 3.91% from the previous closing price of $1.28. In other words, the price has increased by $3.91 from its previous closing price. On the day, 10.43 million shares were traded. GERN stock price reached its highest trading level at $1.37 during the session, while it also had its lowest trading level at $1.28.
Ratios:
Our analysis of GERN’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 6.97 and its Current Ratio is at 7.87. In the meantime, Its Debt-to-Equity ratio is 0.92 whereas as Long-Term Debt/Eq ratio is at 0.86.
On May 08, 2025, Scotiabank Downgraded its rating to Sector Perform which previously was Sector Outperform but kept the price unchanged to $1.50.
B. Riley Securities Downgraded its Buy to Neutral on February 27, 2025, whereas the target price for the stock was revised from $3.50 to $2.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on May 09 ’25 when LAWLIS V BRYAN bought 13,300 shares for $1.18 per share. The transaction valued at 15,667 led to the insider holds 13,300 shares of the business.
Samuels Scott Alan bought 15,000 shares of GERN for $24,150 on Feb 27 ’25. The EVP, Chief Legal Officer now owns 26,682 shares after completing the transaction at $1.61 per share. On Feb 27 ’25, another insider, SCARLETT JOHN A, who serves as the Chairman, President and CEO of the company, bought 12,500 shares for $1.76 each. As a result, the insider paid 22,062 and bolstered with 12,500 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, GERN now has a Market Capitalization of 847100992 and an Enterprise Value of 572001600. For the stock, the TTM Price-to-Sale (P/S) ratio is 7.28 while its Price-to-Book (P/B) ratio in mrq is 3.16. Its current Enterprise Value per Revenue stands at 4.919 whereas that against EBITDA is -4.277.
Stock Price History:
The Beta on a monthly basis for GERN is 0.74, which has changed by -0.6899767 over the last 52 weeks, in comparison to a change of 0.17774606 over the same period for the S&P500. Over the past 52 weeks, GERN has reached a high of $4.89, while it has fallen to a 52-week low of $1.17. The 50-Day Moving Average of the stock is -6.34%, while the 200-Day Moving Average is calculated to be -47.03%.
Shares Statistics:
GERN traded an average of 10.33M shares per day over the past three months and 7834120 shares per day over the past ten days. A total of 636.92M shares are outstanding, with a floating share count of 603.39M. Insiders hold about 5.26% of the company’s shares, while institutions hold 75.85% stake in the company. Shares short for GERN as of 1751241600 were 62985757 with a Short Ratio of 6.10, compared to 1748563200 on 64584701. Therefore, it implies a Short% of Shares Outstanding of 62985757 and a Short% of Float of 10.34.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
